CH
APOPW

CVI Holdings’s Cellect Biotechnology Ltd. Warrants to Purchase ADRs APOPW Stock Holding History

CVI Holdings’s Portfolio APOPW Stock Details APOPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,498
Closed – – 56
2019
Q3 		$0 Hold
12,498
– – ﹤0.01% 76
2019
Q2 		$1K Hold
12,498
– – ﹤0.01% 60
2019
Q1 		$1K Hold
12,498
– – ﹤0.01% 54
2018
Q4 		$4K Sell
12,498
-72
-0.6% -$92 0.01% 37
2018
Q3 		$23K Hold
12,570
– – 0.04% 34
2018
Q2 		$25K Hold
12,570
– – 0.03% 42
2018
Q1 		$24K Buy
+12,570
New +$28.5K 0.03% 39

Other funds holding APOPW

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CVI Holdings's APOPW Position: Q4 2019 in Review

CVI Holdings sold out of Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) in Q4 2019, closing a stake of 12,498 shares.

CVI Holdings first reported a position in APOPW in Q1 2018 and held it in 7 quarters. The position peaked at $25K in Q2 2018. 1 fund tracked by Wall St. Rank holds APOPW as of Q4 2019.

  • CVI Holdings reported no remaining Cellect Biotechnology Ltd. Warrants to Purchase ADRs position as of Q4 2019 after selling out during the quarter.
  • CVI Holdings sold 12,498 Cellect Biotechnology Ltd. Warrants to Purchase ADRs shares in Q4 2019.
  • CVI Holdings first reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in Q1 2018 and held it in 7 quarters.
  • CVI Holdings's Cellect Biotechnology Ltd. Warrants to Purchase ADRs position peaked at $25K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Cellect Biotechnology Ltd. Warrants to Purchase ADRs as of Q4 2019.

Based on CVI Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.